These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35686471)

  • 1. Editorial Comment to Genomic landscape of treatment-naïve urological cancers using next-generation sequencing-based panel test in the Japanese population.
    Shimizu T; Ukimura O
    Int J Urol; 2022 Aug; 29(8):911-912. PubMed ID: 35686471
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic landscape of treatment-naïve urological cancers using next-generation sequencing-based panel test in the Japanese population.
    Mizutani K; Hirade K; Sugiyama S; Kato Y; Nishihara H; Ishihara S
    Int J Urol; 2022 Aug; 29(8):909-911. PubMed ID: 35610466
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For.
    Salami SS
    Eur Urol Focus; 2022 May; 8(3):637-638. PubMed ID: 35817702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status and prospects of gene therapy for urologic cancer. First Meeting of the Japanese Society for Urological Gene Therapy. November 20, 1999. Okayama, Japan.
    Mol Urol; 2000; 4(2):37-87. PubMed ID: 12362879
    [No Abstract]   [Full Text] [Related]  

  • 5. Next generation sequencing and urologic cancer.
    Kim SK; Kim WJ
    Korean J Urol; 2015 Feb; 56(2):87-9. PubMed ID: 25685294
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
    Abern MR; Dudinec JV; Inman BA
    Eur Urol Focus; 2022 May; 8(3):639-640. PubMed ID: 35537938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment.
    Lotan Y; Merseburger AS
    Curr Opin Urol; 2017 Jan; 27(1):34. PubMed ID: 27902674
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
    Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
    Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic sequencing of the novel HLA-C*07:02:01:107 allele by next-generation sequencing in two Japanese individuals.
    Khor SS; Omae Y; Tokunaga K
    HLA; 2022 Oct; 100(4):383-384. PubMed ID: 35709162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status and prospects of gene therapy for urologic cancer.
    Kumon H
    Mol Urol; 2000; 4(2):39-40. PubMed ID: 12006238
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetics of Urological Cancers.
    Schulz WA; Sørensen KD
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Progress of Epigenetic Biomarkers in Urological Cancer.
    Wu P; Cao Z; Wu S
    Dis Markers; 2016; 2016():9864047. PubMed ID: 27594736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.
    Tateo V; Cigliola A; Mercinelli C; Agarwal N; Grivas P; Kamat AM; Gibb EA; Moschini M; Brausi M; Dyrskjøt L; Loriot Y; Gupta S; Colecchia M; Spiess PE; Ross JS; Necchi A
    Clin Genitourin Cancer; 2024 Aug; 22(4):102091. PubMed ID: 38735133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0).
    Sunami K; Takahashi H; Tsuchihara K; Takeda M; Suzuki T; Naito Y; Sakai K; Dosaka-Akita H; Ishioka C; Kodera Y; Muto M; Wakai T; Yamazaki K; Yasui W; Bando H; Fujimoto Y; Fukuoka S; Harano K; Kawazoe A; Kimura G; Koganemaru S; Kogawa T; Kotani D; Kuboki Y; Matsumoto H; Matsumoto S; Mishima S; Nakamura Y; Sawada K; Shingaki S; Shitara K; Umemoto K; Umemura S; Yasuda K; Yoshino T; Yamamoto N; Nishio K; ; ;
    Cancer Sci; 2018 Sep; 109(9):2980-2985. PubMed ID: 30187675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
    Agarwal N; Pal SK; Hahn AW; Nussenzveig RH; Pond GR; Gupta SV; Wang J; Bilen MA; Naik G; Ghatalia P; Hoimes CJ; Gopalakrishnan D; Barata PC; Drakaki A; Faltas BM; Kiedrowski LA; Lanman RB; Nagy RJ; Vogelzang NJ; Boucher KM; Vaishampayan UN; Sonpavde G; Grivas P
    Cancer; 2018 May; 124(10):2115-2124. PubMed ID: 29517810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for urological cancer.
    Pandha HS; Sikora K
    Br J Urol; 1995 Jun; 75 Suppl 1():67-74. PubMed ID: 7613859
    [No Abstract]   [Full Text] [Related]  

  • 17. Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?
    Rodler S; Jung A; Greif PA; Rühlmann K; Apfelbeck M; Tamalunas A; Kretschmer A; Schulz GB; Szabados B; Stief C; Heinemann V; Westphalen CB; Casuscelli J
    Eur J Cancer; 2021 Mar; 146():1-10. PubMed ID: 33535139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine.
    Hatanaka Y; Kuwata T; Morii E; Kanai Y; Ichikawa H; Kubo T; Hatanaka KC; Sakai K; Nishio K; Fujii S; Okamoto W; Yoshino T; Ochiai A; Oda Y
    Pathol Int; 2021 Nov; 71(11):725-740. PubMed ID: 34614280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of gene therapy in the treatment of urological tumors].
    Heidenreich A; von Knobloch R; Hofmann R
    Urologe A; 1999 Nov; 38(6):603-13. PubMed ID: 10591808
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
    Kikuchi J; Ohhara Y; Takada K; Tanabe H; Hatanaka K; Amano T; C Hatanaka K; Hatanaka Y; Mitamura T; Kato M; Shibata Y; Yabe I; Endoh A; Komatsu Y; Matsuno Y; Sugiyama M; Manabe A; Sakurai A; Takahashi M; Naruse H; Torimoto Y; Dosaka-Akita H; Kinoshita I
    Jpn J Clin Oncol; 2021 Apr; 51(5):753-761. PubMed ID: 33532831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.